HealthLeaders Media June 18, 2024
Eric Wicklund

The founder and CEO of a medical device company has been convicted of selling an implantable medical device to providers that didn’t work at all—and then creating a replacement part that was also fake.

KEY TAKEAWAYS

– Innovative healthcare technology often holds the promise of improving clinical outcomes, but providers need to do due diligence on those vendors.

– New York authorities have convicted the founder and CEO of a medical device company that marketed a fake implantable neurostimulator.

– The executive was convicted of passing off a piece of plastic as a part of the device that could be implanted in a patient and receive electric charges.

Healthcare executives looking to embrace the latest in implantable technology for patient...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Provider
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article